Diagnostic Tools

DiagnosticTools Business News

Diagnostic Tools Jobs

Find an open position today!

CombiMatrix And Clarient To Market And Sell The HemeScan Cancer Test

CombiMatrix Corporation and Clarient will be collaborating to commercialized the novel cancer test HemeScan. by Tristan Estoppey , 06/02/2008

A World Leader In Cancer Molecular Diagnostics

by Fabio Ferfoglia, PhD, 20/12/2007


DiagnosticTools Headlines




DiagnosticTools Partnerships
September 7th, 2010, Roche and reMYND announced that they had entered into an agreement to develop novel therapeutics that could slow down neurodegeneration in Parkinson's and Alzheimer's patients by inhibiting alpha-synuclein and tau toxicity.
January 6th, 2010, Alnylam Pharmaceuticals announced that it had received a milestone payment from its partner Roche related to initiation of pre-IND (investigational new drug application) studies for an RNAi therapeutics product candidate. Financial terms of the milestone were not disclosed.
August 25th, 2008, Genzyme and Medicines for Malaria Venture (MMV) announced a new collaboration with Advinus Therapeutics Ltd. The collaboration seeks to develop new, improved treatments for specific patient groups most at risk for malaria, an often fatal infectious disease of developing countries, particularly affecting pregnant women and infants.